English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2543897      線上人數 : 217
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/4900


    題名: 台灣腸胃道間質腫瘤之發生率,免疫化學染色及基因突變之分析研究
    Gastrointestinal stromal tumors in Taiwan: The incidence, immunohistochemical staining and mutation analysis
    作者: 王曼寧
    Man-Ning WANG
    貢獻者: 醫學檢驗暨生物技術學研究所
    關鍵詞: 腸胃道間質腫瘤
    發生率
    基因突變
    GIST
    incidence
    KIT mutation
    日期: 2005
    上傳時間: 2009-09-10 17:20:09 (UTC+8)
    摘要: 腸胃道基質瘤(gastrointestinal stromal tumor, GIST)乃是源自腸胃壁肌肉層的腫瘤,是最常見的間質腫瘤。其診斷的標準在1997年被重新定義。因為新的分子標靶藥物對轉移及某些腸胃道基質瘤具有療效,因此我們想知道目前台灣在新的定義之下,此腫瘤的發生率,以及研究其免疫染色的特性以及基因突變與預後的相互情形。由馬偕醫院1998年至2004年的17850個腸胃道腫瘤中篩選出108個符合新定義的腸胃道間質腫瘤進行統計及研究分析,並以 CD117、CD34、 S-100及SMA,4種抗體進行免疫染色,以及KIT及PDGFRA的基因分析,並且將其突變分類,比較不同形式的突變與沒有突變的腫瘤其預後情況是否有統計上的差別。統計所得台灣的腸胃道間質腫瘤的發生率為約每百萬人有13.74人罹病,其盛行率為每百萬人有303.60人。免疫染色研究之結果顯示CD117免疫染色研究之結果顯示CD117陰性的腸胃道間質腫瘤亦有基因突變的情形發生,而此類腫瘤其組織型態並無特別的。KIT 基因突變情形在exon 9、11、13、17分別為13/134 (9.7 %)、79/134 (59 %)、0/134 (0 %) and 0/134 (0 %)。PDGFRA基因突變情形則只在exon 12 發生1/134 (0.07 %),這樣的結果與目前大多數的文獻報告類似。而我們發現不同突變的型態也會有不同的預後情形; 此篇研究奠定重新定義之後,台灣腸胃道間質腫瘤的發生率,及其免疫化學染色之特性及KIT 和PDGFRA基因在此腫瘤的情形。
    Gastrointestinal stromal tumors (GIST) are the most common mesencymal tumors in gastrointestinal tract. The diagnostic criteria of GISTs had been redefined. Because of the new target therapy was successfully in unresectable or metastatic GIST patients, We examined the incidence, prevalence, immunohistochemical staining and mutation analysis in Taiwan. All patients (n=17850) who had primary mesenchymal tumors of the gastrointestinal tract in Mackay memorial hospital from 1998 to 2004 were selected to screen; and 108 patients were identified.The incidence and prevalence of GIST in Taiwan were analyzed statistically. Immunohistochemically, each tumor was staining for CD117,S-100, and alpha smooth muscle actin (SMA). KIT (exons 9,11,13and 17) and PDGFRA (exons 10,12,14 and 18) were sequenced to identify the mutation. The annual incidence of GIST in Taiwan was 13.74 per million. The prevalence of GIST in Taiwan was 303.60 per million. Immunophenotypically, tumors expressed CD117 (97/134),alpha-SMA (8/134),desmin (1/134),S-100 protein (10/134).The KIT gene mutations of exon 9,11,13 and 17 were found in 13/134 (9.7%),79/134 (59%),0/134 (0%) and 0/134 (0%).The PDGFRA gene mutations only found in exon 12, 1/134 (0.7 %). The incidence and prevalence of GIST in Taiwan was determined. The mutation rate of KIT was similar with other published reports but that of PDGFRA was lower than those. This article summarizes the incidence, molecular biology of GIST in Taiwan.
    資料類型: thesis
    顯示於類別:[醫學檢驗暨生物技術學系所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc28KbMicrosoft Word115檢視/開啟
    摘要.pdf64KbAdobe PDF315檢視/開啟
    摘要.ppt132KbMicrosoft Powerpoint193檢視/開啟
    摘要.ps354KbPostscript61檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋